...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF up 290% to $0.16...question

"In my opinion, ZCC (Zenith Epigenetics as we know it) needed to set this up on the OTC in the first place for the shares to be traded on the OTC."

How can that be true?  You've already stated that the ZENI.P CEO told you they don't trade on the OTC.  So neither company set this up.

"Before a company can post a quote for its OTC security, it must first recruit a market maker to sponsor the issue."

Not according to the ZHCLF page at OTC Markets: "Investors should be aware that no firm is making a market in this stock on OTC Link. All prices reflect unsolicited customer orders and investors may have a difficult time selling this stock."

https://www.otcmarkets.com/stock/ZHCLF/overview

Share
New Message
Please login to post a reply